Parkinson's Disease Trial, Recruiting NCT07488364 Sponsor: Acibadem University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07488364
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with Parkinson's disease
  • People whose Parkinson's disease falls within stages 1 to 3 on a standard severity scale called the Hoehn and Yahr scale (confirm with trial site)
  • People aged between 40 and 85 years
  • People who score 24 or above on a standard memory and thinking test called the Mini-Mental State Examination (MMSE)
  • People who are currently attending a Movement Disorders Outpatient Clinic in the Neurology department
  • People who are able to understand what the study involves and are willing to sign a written consent form

Who may not be able to join:

  • People who have a diagnosis of major depression or a psychotic disorder
  • People who have advanced dementia
  • People who have severe heart or lung disease
  • People who have a long-term illness such as diabetes or high blood pressure that is not well controlled
  • People who have an additional neurological condition or a bone or joint condition that could affect how they perform during assessments
  • People who have serious vision or hearing problems that could interfere with the study assessments
  • People who would not be able to cooperate with a physiotherapist during the study assessments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05324251290

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Acibadem University
Registry
ClinicalTrials.gov
Start date
30 March 2026
Est. completion
30 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Vividness of Movement Imagery Questionnaire-2 (VMIQ-2) Total and Subscale Scores; Multidimensional Assessment of Interoceptive Awareness-2 (MAIA-2) Total and Subscale Scores; Fried Frailty Phenotype (FFP) Classification and Total Criteria Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov